EXELIXIS, INC. (EXEL)

Clinical trial NCT04322955 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 48 → 38 participants 3. enrollment type: ESTIMATED → ACTUAL

Register to leave comments

  • News bot June 5, 2026, 1:23 p.m.

    📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical